Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  
Google
Web www.equitybulls.com
Research

| More

Mahindra CIE Automotive - CY20 performance closes on a strong note - ICICI Securities

Posted On: 2021-02-22 04:59:34 (Time Zone: Arizona, USA)


Mahindra CIE Automotive's (MACA) Q4CY20 operating margins were ahead of consensus estimates. Consolidated sales rose ~14% YoY to Rs16.4bn. India revenue share in Q4 (52%) surpassed Europe (48%) while India PBT contribution rose to ~64%. India business clocked six-quarter high margins at ~15.3% (up ~271bps YoY) while clocking ~17% revenue growth. MACA incurred incremental costs to streamline Europe operations, which restricted margins (down 86bps at 11.9%). Company registered healthy FCF of ~Rs2bn in CY20, and we expect cumulative FCF of ~Rs11.8bn over CY21E-CY22E. We expect India revenues to grow at ~20% CAGR CY20-CY22E driven by market growth and new order wins. Bulk (>60%) of MACA's profitability (PBT) is now driven by India business while consensus still seems focussed on the Europe business. Stock remains undervalued (~11x P/E / 9% FCF yield on CY22E basis). Maintain BUY.

- Key highlights of the quarter: Consolidated revenues rose 13.9% YoY driven by India region growth of 17% at Rs9.7bn while Europe business was also up 7.1% to ~Rs8.9bn. India business grew on the back of new customer additions (25 added in CY20). Consolidated EBITDA margin rose only 99bps to ~13.7% inclusive of the additional cost to streamline the Europe business. India business has crossed the 15% CIE margin target (clocked ~15.3%) even as the industry cycle enters a growth phase in CY21/CY22. Consolidated PBT grew ~33% to ~Rs1.6bn.

- Margin improvement delivered; growth to be driven by new products: Management has laid out a growth strategy focused on value-added products in the domestic market, and higher exports. India is expected to drive revenue growth while the focus in Europe remains on: a) improving profitability, and b) increasing new product sales (e.g. knuckles) in European PV business to mitigate the impact of BEV sales increase. Strong cost reduction exercises have reduced breakeven levels across both India and Europe. Management expects the tailwinds of China-plus global supply chain rejig, PLI scheme and increased outsourcing from CIE to aid export growth for MACA.

- Maintain BUY: We believe MACA is a well-diversified MNC with India revenue/PBT share reaching ~51%/63% in H2CY20. We raise our estimates (by ~6%/4% for CY21E/CY22E respectively) factoring-in the better margin trajectory in domestic business. We raise our target multiple in view of the rise in contribution of India profitability to 15x (earlier: 13x) CY22E EPS of Rs17.1. Maintain BUY with a revised target price of Rs253/share (earlier: Rs213).

Shares of Mahindra CIE Automotive Limited was last trading in BSE at Rs.179.7 as compared to the previous close of Rs. 190.2. The total number of shares traded during the day was 50782 in over 847 trades.

The stock hit an intraday high of Rs. 198 and intraday low of 176.9. The net turnover during the day was Rs. 9541231.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com


Disclaimer:The article above is a gist / extract of the original report prepared by the research firm / brokerage firm. This article is not to be considered as an offer to sell or a solicitation to buy any securities. This article is meant for general information only. www.equitybulls.com, its employees or owners or the research firms, its employees or owners won't be responsible for any liability that may arise from information, errors or omissions in these articles. www.equitybulls.com or its employees or owners / the research firms or its employees or clients or owners may from time to time hold positions in securities referred in this article. For detailed research reports, please contact the concerned research firm directly.





Other Headlines:

Emerging Lenders Day - Conference Takeaways - YES Securities

Cement - Prices rise; earnings upgrade to continue - ICICI Securities

Affle India - Navigating privacy and technology challenges will be the key - ICICI Securities

IT Sector Investor Forum - Onwards and upwards - HDFC Securities Institutional Research Desk

Wipro - Beware of integration / impairment risks! - ICICI Securities

Easy Trip Planners Ltd - IPO Review - ICICI Direct

ICICI Direct - Derivatives Weekly View (March 5): Level of 14700 remains crucial for upsides to continue...

Easy Trip Planners Ltd. - IPO - Strong Financials - Reliance Securities

Bharat Forge - Initiating Coverage - Constant evolution - HDFC Securities

Mahindra Logistics - Large-ticket deal win - ICICI Securities

Company Update - Huhtamaki India - ICICI Direct

Gladiator Stocks: IndusInd Bank, VIP Industries - ICICI Direct

Warehousing demand expected to grow around 160% to reach 35 million sq. ft in 2021: JLL

Telecom - Spectrum auction: Prudent investment by Bharti Airtel - ICICI Securities

JB Chemicals & Pharmaceuticals - Analyst meet takeaways - ICICI Securities

IPO Review - MTAR Technologies Ltd - ICICI Direct

Auto Sector - Monthly Volume Round-up - Feb 21 - Decent YoY Growth Continues

Aditya Birla Fashion and Retail - Focus on scaling up new businesses - ICICI Securities

Automobiles (wholesale) - Wholesales push continues despite modest retail trends - ICICI Securities

Aditya Birla Capital - Thoughtful (inclusive) conglomerate business evolution commands premium - ICICI Securities

Jubilant Foodworks - Buying in-the-money options - ICICI Securities

Multi Commodity Exchange of India - Play on rising commodity prices? - ICICI Securities

Gladiator Stocks - Sudarshan Chemical - ICICI Direct

Monthly Commodities Outlook - March 2021 - ICICI Direct

ICICI Direct - Monthly Currency Outlook: Rupee to depreciate further towards 75.00 level...

ICICI Direct - Covid Recovery Pulse - E-way bill generation in February 2021 starts on strong note...

Company Update - Virtual JLR Investor Event - Tata Motors - ICICI Direct

Analyst Meet Update - Aditya Birla Fashion and Retail - ICICI Direct

MTAR Technologies Ltd. - IPO - Huge Opportunities from Clean Energy Bodes Well - Reliance Research

ICICI Direct Derivatives Weekly View (February 26): Failure to move above 14700 may extend declines towards 14300...

Bank: Sector Credit Trends - Slows, Yet again - HDFC Securities

Piramal Enterprises - Pharma day highlights - ICICI Securities

Polymer price tracker - PVC prices rise sharply again! - ICICI Securities

Greenply Industries - Growth returns, at an inflection point - ICICI Securities

Tata Motors - JLR future proofing itself with rapid electric transition - ICICI Securities

Dairy - Higher freight cost and increase in Global SMP prices - ICICI Securities

Analyst Meet Update - Nestlé India (Hold): Focus on product innovation, expanding rural reach - ICICI Direct

MTAR Technologies Ltd - A strong player in booming high precision engineering... - Geojit

Rollover Report for February - March 2021 : Angel Broking

Reaction from industry experts on Q3FY21 GDP numbers

M. Govinda Rao, Chief Economic Adviser, Brickwork ratings on Q3FY21 GDP numbers

Mr. Dhiraj Relli, MD & CEO, HDFC securities views on Q3FY21 GDP Growth Number

Suman Chowdhury, Chief Analytical Officer, Acuité Ratings & Research on Q3FY21 GDP

Rollover Analysis - Feb 21, 2021 - YES Securities

Consumer Durables - Demand-driven recovery continues - HDFC Securities

Cement - Demand surprises; earnings upgrade to continue - ICICI Securities

Gladiator Stocks - TeamLease Services - ICICI Direct

Gladiator Stocks - Metals to outshine post multi-year breakout... - ICICI Direct

Company Update - Sundaram Finance - ICICI Direct

Indian pharmaceutical industry to meet an ambition of US$130 billion by 2030 through innovation-led growth: EY-FICCI report



Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2020